Reports emerged that SmartKem, a tiny semiconductor materials company, announced a 1-for-50 reverse stock split on August 19, 2026 — a last-ditch maneuver to keep its shares listed on the Nasdaq exchange, which requires stocks to trade above $1.00. With shares sitting at roughly $0.09, the company is effectively admitting the market has lost confidence in its near-term value, and it needs financial engineering rather than business performance to stay on the board. SmartKem's 1-for-50 Reverse Split Buys Time on Nasdaq, but Can a Sub-Penny Stock Engineering Its Price Tag Survive?
Shares held steady at $0.09 as SmartKem disclosed a 1-for-50 reverse stock split — its second such maneuver in three years — to avoid being kicked off the Nasdaq exchange. For a company with a $4.3 million market value, $694,000 in trailing revenue, and an auditor warning about its ability to stay in business, this is less a strategic reset than a survival reflex.
This Is the Second Reverse Split Since 2023, and the Math Keeps Getting Worse. SmartKem's last reverse split came in September 2023, at a 1-for-35 ratio. The new 1-for-50 consolidation will shrink approximately 21.4 million shares into roughly 429,000 — mechanically boosting the per-share price to around $4.50. But a higher sticker price does not create value. The stock has plunged nearly 79% over the past 52 weeks , and history shows that serially reverse-splitting micro-caps tend to resume their slide once temporary attention fades.
The Company Is Burning Cash With Almost Nothing Coming In. SmartKem has generated no commercial-scale revenue and posted a $13.0 million comprehensive loss in 2025, with an accumulated deficit of $125.1 million.
Cash on hand stood at just $0.4 million as of year-end 2025, a figure management and auditors called insufficient for twelve months — triggering formal going-concern doubt. First-quarter 2026 revenue was just $20,000.
A Proposed Merger and Dilution Tools Cloud the Outlook. In August 2026, SmartKem announced an all-stock merger with Ferrox Critical Minerals, valued at $125 million. Meanwhile, shareholders approved expanding authorized shares from 300 million to 5 billion and gave the board power to issue stock below Nasdaq's minimum price — tools that open the door to massive dilution. During early 2026, SmartKem also transferred its patent portfolio to a third party , retaining only trade secrets, further hollowing out tangible assets.
Nasdaq Was Already Moving to Delist. In February 2026, Nasdaq staff formally notified SmartKem of a delisting determination over continued non-compliance with equity requirements , and the company requested a hearing to stall the process. The reverse split addresses the price rule, but does nothing to resolve the deeper equity shortfall.
Bottom line: The reverse split is a tourniquet, not a cure. With virtually no revenue, negligible cash, and a speculative merger on the table, SmartKem is asking investors to bet on a corporate transformation that has yet to materialize.